<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="EUR" hierarchy="2" humanitarian="0" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>BE-BCE_KBO-0410057701-PROG17-21_07OC1</iati-identifier>
  <reporting-org ref="BE-BCE_KBO-0410057701" type="15">
   <narrative xml:lang="EN">Instituut voor Tropische Geneeskunde</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">PROG17-21_07OC1_To strengthen the Institute of Tropical Medicine Alexander von Humboldt (IMTAvH)&apos;s Research and Development (R&amp;D) capacities to deliver strategies and/or tools for diagnosis, surveillance and control of infectious diseases</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">The Institute of Tropical Medicine Alexander von Humboldt has a longstanding relationship with the Institute of Tropical Medicine of Antwerp in the frame of fundamental and translational research for improving health. We have developed over the years a strong partnership in the area of infectious diseases that pose significant public health concerns in Peru and the Latin American region (and globally as well): leishmaniasis, malaria, tuberculosis (TB), human T-lymphotropic virus-1 (HTLV-1) associated diseases, and bacterial diseases. Current proposal builds further on the acquired knowledge and experience, and includes an additional component on arboviral infections. Through scientific collaboration, we believe we can have a positive effect on treatment and prevention of the mentioned conditions, by acting at various levels. While the leishmaniasis, HTLV-1, and arbovirus components focus on development of field-applicable diagnostic assays, malaria is developing a point-of-care (POC) diagnostic tool for vulnerable populations and molecular tools for surveillance (in view of malaria elimination), and TB research is directed on surveillance and prevention. Further, we can positively impact treatment of bacterial diseases by monitoring of resistance against antimicrobial agents. In all these domains, we will work in settings relevant for the patients or populations at risk. Further, we will strengthen local human capacity in the institute by supporting doctoral and postdoctoral researchers.</narrative>
  </description>
  <participating-org activity-id="XM-DAC-2-10-1111" ref="XM-DAC-2-10" role="1" type="10">
   <narrative xml:lang="EN">Belgian Development Cooperation</narrative>
  </participating-org>
  <participating-org activity-id="BE-BCE_KBO-0410057701-PROG17-21_07OC1" ref="BE-BCE_KBO-0410057701" role="2" type="80">
   <narrative xml:lang="EN">Instituut voor Tropische Geneeskunde</narrative>
  </participating-org>
  <participating-org activity-id="BE-BCE_KBO-0410057701-PROG17-21_07OC1" ref="BE-BCE_KBO-0410057701" role="4" type="80">
   <narrative xml:lang="EN">Instituut voor Tropische Geneeskunde</narrative>
  </participating-org>
  <participating-org role="4" type="80">
   <narrative xml:lang="EN">Universidad Peruana Cayetano Heredia</narrative>
  </participating-org>
  <activity-status code="4"></activity-status>
  <activity-date iso-date="2017-01-01" type="1"></activity-date>
  <activity-date iso-date="2017-01-01" type="2"></activity-date>
  <activity-date iso-date="2021-12-31" type="3"></activity-date>
  <activity-date iso-date="2021-12-31" type="4"></activity-date>
  <contact-info type="1">
   <department>
    <narrative xml:lang="EN">Project Management</narrative>
   </department>
   <email>dgdprojectenbeheer@itg.be</email>
  </contact-info>
  <recipient-country code="PE" percentage="100"></recipient-country>
  <location>
   <name>
    <narrative xml:lang="EN">Lima</narrative>
   </name>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>-12.033948163635914 -77.04711914062499</pos>
   </point>
  </location>
  <sector code="12182" percentage="100" vocabulary="1"></sector>
  <policy-marker code="1" significance="1" vocabulary="1"></policy-marker>
  <policy-marker code="2" significance="1" vocabulary="1"></policy-marker>
  <policy-marker code="5" significance="1" vocabulary="1"></policy-marker>
  <policy-marker code="9" significance="1" vocabulary="1"></policy-marker>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="30"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="2" type="2">
   <period-start iso-date="2017-01-01"></period-start>
   <period-end iso-date="2017-12-31"></period-end>
   <value currency="EUR" value-date="2017-01-01">507537.74</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2018-01-01"></period-start>
   <period-end iso-date="2018-12-31"></period-end>
   <value currency="EUR" value-date="2018-01-01">700642.56</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2019-01-01"></period-start>
   <period-end iso-date="2019-12-31"></period-end>
   <value currency="EUR" value-date="2019-01-01">629719.01</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2020-01-01"></period-start>
   <period-end iso-date="2020-12-31"></period-end>
   <value currency="EUR" value-date="2020-01-01">478079.45</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-01-01"></period-start>
   <period-end iso-date="2021-12-31"></period-end>
   <value currency="EUR" value-date="2021-01-01">938543.12</value>
  </budget>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2017-01-01"></transaction-date>
   <value currency="EUR" value-date="2017-01-01">1421026.42</value>
   <provider-org provider-activity-id="BE-BCE_KBO-0410057701-PROG2017-2021" ref="BE-BCE_KBO-0410057701" type="15"></provider-org>
   <receiver-org>
    <narrative xml:lang="ES">Universidad Peruana Cayetano Heredia</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2017-12-31"></transaction-date>
   <value currency="EUR" value-date="2017-12-31">247016.74</value>
   <provider-org provider-activity-id="BE-BCE_KBO-0410057701-PROG2017-2021" ref="BE-BCE_KBO-0410057701" type="15"></provider-org>
   <receiver-org>
    <narrative xml:lang="ES">Universidad Peruana Cayetano Heredia</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2018-12-31"></transaction-date>
   <value currency="EUR" value-date="2018-12-31">364174.56</value>
   <provider-org provider-activity-id="BE-BCE_KBO-0410057701-PROG2017-2021" ref="BE-BCE_KBO-0410057701" type="15"></provider-org>
   <receiver-org>
    <narrative xml:lang="ES">Universidad Peruana Cayetano Heredia</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="EUR" value-date="2019-12-31">293161.66</value>
   <provider-org provider-activity-id="BE-BCE_KBO-0410057701-PROG2017-2021" ref="BE-BCE_KBO-0410057701" type="15"></provider-org>
   <receiver-org>
    <narrative xml:lang="ES">Universidad Peruana Cayetano Heredia</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="EUR" value-date="2020-12-31">210000</value>
   <provider-org provider-activity-id="BE-BCE_KBO-0410057701-PROG2017-2021" ref="BE-BCE_KBO-0410057701" type="15"></provider-org>
   <receiver-org>
    <narrative xml:lang="ES">Universidad Peruana Cayetano Heredia</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="EUR" value-date="2021-12-31">543174.28</value>
   <provider-org provider-activity-id="BE-BCE_KBO-0410057701-PROG2017-2021" ref="BE-BCE_KBO-0410057701" type="15"></provider-org>
   <receiver-org>
    <narrative xml:lang="ES">Universidad Peruana Cayetano Heredia</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2017-12-31"></transaction-date>
   <value currency="EUR" value-date="2017-12-31">226588.81</value>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2018-12-31"></transaction-date>
   <value currency="EUR" value-date="2018-12-31">306819.26</value>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="EUR" value-date="2019-12-31">263623.96</value>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="EUR" value-date="2020-12-31">204635.25</value>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="EUR" value-date="2021-12-31">409039.81</value>
  </transaction>
  <related-activity ref="BE-BCE_KBO-0410057701-PROG17-21" type="1"></related-activity>
  <conditions attached="0"></conditions>
  <result aggregation-status="0" type="2">
   <title>
    <narrative xml:lang="EN">To strengthen the IMTAvH R&amp;D capacities to deliver strategies and/or tools for diagnosis, surveillance and control of infectious diseases</narrative>
   </title>
   <indicator aggregation-status="0" ascending="1" measure="1">
    <title>
     <narrative xml:lang="EN">Number of grants submitted by researchers from the IMTAvH-ITM collaboration (cumulatif)</narrative>
    </title>
    <description>
     <narrative xml:lang="EN">Both research and training grants submitted. Sum of the two, but separate list is kept to track both.</narrative>
    </description>
    <baseline value="0" year="2017"></baseline>
    <period>
     <period-start iso-date="2017-01-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target value="10"></target>
     <actual value="43">
      <comment>
       <narrative xml:lang="EN">43 research and training grants were submitted by researchers trained in the collaboration. Of these, 22 (51%) were awarded.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2017-01-01"></period-start>
     <period-end iso-date="2019-12-31"></period-end>
     <target value="5"></target>
     <actual value="38">
      <comment>
       <narrative xml:lang="EN">Includes both research and training grants</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="1">
    <title>
     <narrative xml:lang="EN">Number of publications by researchers from the IMTAvH-ITM collaboration</narrative>
    </title>
    <baseline value="0" year="2017"></baseline>
    <period>
     <period-start iso-date="2017-01-01"></period-start>
     <period-end iso-date="2019-12-31"></period-end>
     <target value="5"></target>
     <actual value="11">
      <comment>
       <narrative xml:lang="EN">2017 n = 4 2019 n = 7</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2017-01-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target value="10"></target>
     <actual value="17">
      <comment>
       <narrative xml:lang="EN">2017 n = 4 ; 2019 n = 7 ; 2020 n = 3 ; 2021 n= 3</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator aggregation-status="0" ascending="1" measure="1">
    <title>
     <narrative xml:lang="EN">Number of PhDs with doctoral training completed</narrative>
    </title>
    <baseline value="0" year="2017"></baseline>
    <period>
     <period-start iso-date="2017-01-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target value="4"></target>
     <actual value="1">
      <comment>
       <narrative xml:lang="EN">One PhD was completed:
Functional characterization of Leishmania throughout in vitro biological cycle: the quest for a quiescent stage among amastigotes.
MARLENE JARA-PORTOCARRERO
March 27, 2019

Of the remaining 3 PhDs, 2 are in the final stage of completion, while 1 was stopped after 2 years.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2017-01-01"></period-start>
     <period-end iso-date="2019-12-31"></period-end>
     <target value="1"></target>
     <actual value="1"></actual>
    </period>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
